Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline for hospitalized adults with COVID-19
IRCT20201117049427N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of doxycycline in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Need for ICU admission and Duration of hospitalization. Started Dec 2020; status: completed.
02
Drugs
doxycycline
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20201117049427N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201117049427N1.